Accueil / Tag Archives: Pharmaceutical

Tag Archives: Pharmaceutical

Granules India to Add 102 Jobs, Invest $35 Million in Fairfax County Pharmaceutical R&D, Manufacturing Operation

Monday, May 22nd 2017 at 2:30pm UTC Hyderabad-based company expanding presence in Chantilly area FAIRFAX COUNTY, Va.–(BUSINESS WIRE)– Governor Terry McAuliffe today announced that Granules India Ltd., a vertically integrated pharmaceutical company, will invest $35 million into its wholly owned subsidiary, Granules Pharmaceuticals Inc., to expand its pharmaceutical R&D and …

Plus »

GlycoMimetics’ GMI-1271 Receives EU Orphan Drug Designation for Acute Myeloid Leukemia

Thursday, May 25th 2017 at 1:25pm UTC ROCKVILLE, Md.–(BUSINESS WIRE)– GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that the European Commission, based on a favorable recommendation from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products, has granted orphan designation for the company’s drug candidate GMI-1271 for the treatment of …

Plus »

Ligand to Participate in Two Upcoming Investor Conferences

Monday, May 22nd 2017 at 1:00pm UTC SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following upcoming investor conferences: 14th Annual Craig-Hallum Institutional Investor Conference in Minneapolis. Conference takes place on Wednesday, May 31, 2017 with one-on-one meetings only. John …

Plus »

Origenis Announces Patent Grants for Lead Small Molecule LRRK2 Inhibitors for Treatment of Neurodegenerative and Inflammatory Diseases

Tuesday, May 23rd 2017 at 12:30pm UTC Strengthens IP position in the US, complements grants in other key markets and protects further development of small molecule drugs capable of penetrating the blood-brain barrier MARTINSRIED, Germany–(BUSINESS WIRE)– Origenis GmbH, a privately held biopharmaceutical company developing novel therapeutics to fight neurodegenerative and …

Plus »

Biologics’ Patient Access Services Team Procures More Than $44 Million in Co-Pay Assistance for Cancer Patients in 2016

Wednesday, May 24th 2017 at 1:00pm UTC Rising costs of cancer care threaten access to treatment for many patients CARY, N.C.–(BUSINESS WIRE)– Biologics, Inc., a McKesson Specialty Health oncology pharmacy services company, secured more than $44 million in co-pay assistance in 2016 for commercial patients in need of oral chemotherapy …

Plus »

ICON and Regeneron Win Best Partnership in Clinical Research Award from PharmaTimes

Wednesday, May 24th 2017 at 9:00am UTC ICON & Regeneron recognised for demonstrating successful collaboration between pharma & CRO DUBLIN–(BUSINESS WIRE)– ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and Regeneron Pharmaceuticals, Inc., a leading science-based biopharmaceutical …

Plus »

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

Tuesday, May 23rd 2017 at 8:01pm UTC Transaction adds innovative clinical-stage program to expanding Debiopharm portfolio and broadens its clinical development expertise Divestiture aligns with ImmunoGen’s focus on strategic growth initiatives and generates near-term value LAUSANNE, Switzerland & WALTHAM, Mass.–(BUSINESS WIRE)– Debiopharm International SA (Debiopharm – www.debiopharm.com), part of Debiopharm Group™, a Switzerland-based …

Plus »

Clovis Oncology Announces Presentations at 2017 ASCO Annual Meeting

Tuesday, May 23rd 2017 at 12:00pm UTC Updates on rucaparib clinical trials in multiple solid tumors and therapy settings at ASCO Annual Meeting; top-line data from ARIEL3 pivotal study anticipated by end of June BOULDER, Colo.–(BUSINESS WIRE)– Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that abstracts highlighting progress in the …

Plus »

Akebia Therapeutics Names Rita Jain, M.D. as Chief Medical Officer

Thursday, May 25th 2017 at 12:30pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced the appointment of Rita Jain, M.D. as Senior Vice President and Chief Medical Officer. …

Plus »

Octapharma réaffirme son engagement fort envers les patients atteints d’hémophile A avec la publication de nouvelles données cliniques sur la prophylaxie personnalisée avec nuwiq® basée sur l’analyse PK, suivant l’approche NuPreviq

Wednesday, May 24th 2017 at 1:30pm UTC LACHEN, Suisse–(BUSINESS WIRE)– Octapharma annonce de nouvelles données cliniques positives chez 66 patients préalablement traités (PPT) pour hémophilie A sévère (HA) ayant bénéficié d’une prophylaxie personnalisée basée sur une analyse pharmacinetique (PK) avec Nuwiq®, suivant l’approche NuPreviq. Les données de l’étude NuPreviq (GENA-21, …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...